Full Text
HTA13 How Health Technology Assessment Agencies View Clinical Evidence for Tumor Agnostic Therapies

Abstract

Authors

M Georgallis J Hossain J Uddin

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×